T H Baron1, D E Morgan, S M Vickers, A J Lazenby. Show Affiliations » 1. Department of Internal Medicine, The Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA.
Abstract
Entities: Disease
Mesh： See more » Cilastatin/therapeutic useCilastatin, Imipenem Drug CombinationDrainageDrug CombinationsDrug Therapy, Combination/therapeutic useEndoscopyHumansImipenem/therapeutic useMaleMiddle AgedPancreatitis, Acute Necrotizing/diagnostic imagingPancreatitis, Acute Necrotizing/pathologyPancreatitis, Acute Necrotizing/therapyTomography, X-Ray ComputedTreatment Outcome
Substances： See more » Drug CombinationsCilastatinImipenemCilastatin, Imipenem Drug Combination
Year: 1999 PMID： 10416700
Source DB: PubMed Journal: Pancreas ISSN： 0885-3177 Impact factor: 3.327